Atlas Trials

Ruxolitinib and Lenalidomide for Patients With Myelofibrosis

Clinical trial NCT01375140 · COMPLETED

Trial details

NCT number
NCT01375140
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Myeloproliferative Diseases
Start date
2011-09-22
Primary completion
2018-09-05
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.